MENU
+Compare
FMS
Stock ticker: NYSE
AS OF
Apr 3, 04:59 PM (EDT)
Price
$25.67
Change
+$0.94 (+3.80%)
Capitalization
11.2B

FMS Fresenius Medical Care AG Forecast, Technical & Fundamental Analysis

Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024... Show more

FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FMS with price predictions
Apr 02, 2025

Aroon Indicator for FMS shows an upward move is likely

FMS's Aroon Indicator triggered a bullish signal on April 02, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 266 similar instances where the Aroon Indicator showed a similar pattern. In of the 266 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FMS just turned positive on March 07, 2025. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

FMS moved above its 50-day moving average on March 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FMS crossed bullishly above the 50-day moving average on March 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on April 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FMS as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.762) is normal, around the industry mean (4.616). P/E Ratio (20.797) is within average values for comparable stocks, (71.885). FMS's Projected Growth (PEG Ratio) (0.452) is slightly lower than the industry average of (1.595). Dividend Yield (0.030) settles around the average of (0.026) among similar stocks. P/S Ratio (0.533) is also within normal values, averaging (9.164).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

View a ticker or compare two or three
FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FMS is expected to report earnings to rise 94.17% to 44 cents per share on May 06

Fresenius Medical Care AG FMS Stock Earnings Reports
Q1'25
Est.
$0.45
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.35
Q2'24
Beat
by $0.33
Q1'24
Missed
by $0.04
The last earnings report on February 25 showed earnings per share of 23 cents, missing the estimate of 49 cents. With 194.78K shares outstanding, the current market capitalization sits at 11.20B.
A.I.Advisor
published Dividends

FMS paid dividends on June 03, 2024

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.64 per share was paid with a record date of June 03, 2024, and an ex-dividend date of May 17, 2024. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HFGO21.210.21
+1.00%
Hartford Large Cap Growth ETF
XLF50.160.41
+0.82%
The Financial Select Sector SPDR® ETF
PEY21.540.12
+0.56%
Invesco High Yield Eq Div Achiev™ ETF
BOAT26.61N/A
+0.01%
SonicShares™ Global Shipping ETF
MSOS2.55-0.04
-1.54%
AdvisorShares Pure US Cannabis ETF

FMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FMS has been loosely correlated with FSNUY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then FSNUY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
-0.04%
FSNUY - FMS
52%
Loosely correlated
+0.84%
DVA - FMS
40%
Loosely correlated
+1.57%
DNTCF - FMS
35%
Loosely correlated
+0.34%
OPCH - FMS
25%
Poorly correlated
-0.46%
HCSG - FMS
25%
Poorly correlated
+1.49%
More